Enhanced Diagnostic Tools
Use restrictions. Oligonucleotides and nucleic acid products are manufactured and sold by BSI for the customer’s research purposes only. Resale of BSI products requires the express written consent of BSI. Unless pursuant to a separate signed agreement by authorized BSI officials. BSI products are not sold for (and have not been approved) for use in any clinical, diagnostic or therapeutic applications. Obtaining license or approval to use BSI products in proprietary applications or in any non-research (clinical) applications is the customer’s exclusive responsibility. BSI will not be responsible or liable for any losses, costs, expenses, or other forms of liability arising out of the unauthorized or unlicensed use of BSI products. Purchases of BSI products shall indemnify and hold BSI harmless for any and all damages and/or liability, however characterized, related to the unauthorized or unlicensed use of BSI products. Under no circumstances shall BSI be liable for any consequential damages, resulting from any use (approved or otherwise) of BSI products. All orders received by BSI products, and all sales of BSI, are made subject to the aforementioned use restrictions and customer indemnification of BSI.
General Warning. BSI’s products are guaranteed to meet or exceed our published specifications for identity, purity and yield as measured under normal laboratory conditions. If your product fails to meet such specifications, BSI will promptly replace the product. All other warranties are hereby expressly disclaimed, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose, and any warranty that the products, or the use of products, or the use of products, manufactured by BSI will not infringe the patents of one or more third-parties. All orders received by BSI, and all sales of BSI products are made subject to the aforementioned disclaimers of warranties.
CyTM Dyes. The purchase of this product includes a limited non-exclusive sublicense under U.S. Patent Nos. 5 556 959 and 5 808 044 and foreign equivalent patents and other foreign and U.S. counterpart applications to use the amidites in the product to perform research. NO OTHER LICENSE IS GRANTED EXPRESSLY, IMPLIEDLY OR BY ESTOPPEL. Use of the product for commercial purposes is strictly prohibited without written permission from Amersham Biosciences Corp. For more information concerning availability of additional licenses to practice the patented methodologies, please contact Amersham Biosciences Corp, Business Licensing Manager, Amersham Place, Little Chalfont, Bucks, HP79NA.
BHQ®, Black Hole Quencher, BHQ-0, BHQ-1, BHQ-2 and BHQ-3 are registered trademarks of Bioresearch Technologies, Inc., Novato, California, U.S.A. Patents are currently pending for the BHQ technology and such BHQ technology is licensed by the manufacturer pursuant to an agreement with BTI and these products are sold exclusively for research and development use only. They may not be used for human or veterinary in vitro or clinical diagnostic purposes and they may not be re-sold, distributed or re-packaged. For information on licensing programs to permit use for human or veterinary in vitro or clinical diagnostic purposes, please contact Biosearch at firstname.lastname@example.org.
CAL Fluor®, CAL Fluor and Quasar dyes are registered trademarks of Biosearch Technologies, Inc. Novato, California, U.S.A. Patents are currently pending for the CAL Fluor and Quasar dye technology and such CAL Fluor and Quasar dye technology is licensed by the manufacturer pursuant to an agreement with BTI and these products are sold exclusively for research and development use only. They may not be used for human or veterinary in vitro or clinical diagnostic purposes and they may not be re-sold, distributed or re-packaged.
Invitrogen/MPI dyes. This product is provided under license from Molecular Probes, Inc., for research use only, and is covered by pending and issued patents.
Well-Red® Dyes, BSI manufactured oligonucleotides incorporating Well-Red® Dyes are made and sold under license from Beckman Coulter Inc., (BCI) for use exclusively with BCI instruments or BCI-approved instruments. All other uses are prohibited unless specifically authorized by BCI.
Molecular Beacons. This product is sold under license from the Public Health Research Institute only for use in the purchaser’s research and development activities.
ddRNAi. This product is sold solely for use for research purposes in fields other than plants. This product is not transferable. If the purchaser is not willing to accept the conditions of this label license, supplier is willing to accept the return of the unopened product and provide the purchaser with a full refund. However if the product is opened, then the purchaser agrees to be bound by the conditions of this limited use statement. This product is sold by supplier under license from Benitec Australia Ltd and CSIRO as co-owners of US. Patent No. 6,573,099 and foreign counterparts. For information regarding licenses to these patents for use of ddRNAi as a therapeutic agent or as a method to treat/prevent human disease, please contact Benitec at email@example.com. For the use of ddRNAi in other fields, please contact CSIRO at www.pi.csiro.au/RNAi.
Director™ Dicer Substrate RNAi Duplexes, and other RNAi duplexes
These products are not for use in humans or non-human animals and may not be used for human or veterinary diagnostic, prophylactic or therapeutic purposes. Director™ products sold under license of patents pending jointly assigned to BSI and the City of Hope Medical Center
This product is licensed under European Patents 1144623, 121945 and foreign equivalents from Alnylam Pharmaceuticals, Inc., Cambridge, USA and is provided only for use in academic and commercial research whose purpose is to elucidate gene function, including research to validate potential gene products and pathways for drug discovery and development and to screen non-siRNA based compounds (but excluding the evaluation or characterization of this product as the potential basis for a siRNA-based drug) and not for any other commercial purposes. Information about licenses for commercial use (including discovery and development of siRNA-based drugs) is available from Alnylam Pharmaceuticals, Inc., 300 Third Street, Cambridge MA 02142, USA.
License under U.S. Patent No. 6506559; Domestic and Foreign Progeny: including European Patent Application No. 98964202.
LNAs. Protected by U.S. Patent No. 6,268,490 and foreign applications and patents owned or controlled by Exiqon A/S. For research use only. Not for resale or for therapeutic use of use in humans.
Acrydite. BSI is licensed under U.S. Patent No. 6,180,770 and 5,932,711 to sell this product for use solely in the purchaser’s own life sciences research and development activities. Resale, or use of this product in clinical or diagnostic applications, or other commercial applications, requires a separate license from Mosaic, Inc.
Plexor/Iso-Bases. Licensed under EraGen, Inc., United States Patents Nos. 5,432,272; 6,001,983; 6,037,120; and 6,140,496. For research use only.
Dig. Licensed from Roche Diagnostic GmbH
If you have a query regarding any of our products or services,
please don't hesitate to submit your question below. A member of our support team
will review and answer your question as quickly as possible.